Wonder what will happen next?
Will it be like Medivation acquired by Pfizer for its Xtandi?
Or Immunex acquired by Amgen for its Enbrel?
Or will it be like AnaptysBio partnering with GSK to receive royalties (8-12% ) on the sales of Dostarlimab?
if BP is to acquire Imugene, how would they value other pipelines like OnCARlytic?
A licensing deal would most likely be the outcome?? Anyone kindly shed light on this? Thank you!
Wonder what will happen next?Will it be like Medivation acquired...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
-0.001(1.30%) |
Mkt cap ! $552.6M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.5¢ | $2.417M | 31.59M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 306129 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 2081683 | 39 |
View Market Depth
| Last trade - 15.31pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.6¢ |
Change
-0.001 ( 1.17 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.5¢ | 16148827 | ||
| Last updated 15.52pm 07/05/2024 ? | |||||
| IMU (ASX) Chart |